Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Bayesian Adaptive Marker-Stratified Design for Phase II Clinical Trials Using Calibrated Spike-and-Slab priors.

Statistics in biopharmaceutical research·2026
Same author

An Adaptive Biomarker-based Umbrella Trial Design Using Bayesian Latent Class Model.

Statistics in biopharmaceutical research·2026
Same author

Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.

Signal transduction and targeted therapy·2026
Same author

Modeling context-dependent RNA splicing by deep learning.

Nature computational science·2026
Same author

A retrospective pharmacovigilance analysis based on the FAERS database reveals sex-associated differences in toxicities of CAR T-cell therapy.

Nature communications·2026
Same author

Cancer IDO1-Mediated Tryptophan-Kynurenine Metabolic Reprogramming to Drive Skeletal Muscle Atrophy and Cachexia Acceleration.

Journal of cachexia, sarcopenia and muscle·2026
Same journal

Patient-derived organoids in hematologic malignancies: Fidelity and translation beyond animals.

Trends in cancer·2026
Same journal

Precision neuro-oncology for children: Time to gear up!

Trends in cancer·2026
Same journal

Multi-omics analysis of extracellular vesicle cargo in cancer.

Trends in cancer·2026
Same journal

An immunological panacea for cancer-related cachexia.

Trends in cancer·2026
Same journal

Beyond one gene, one target: Next-generation precision oncology.

Trends in cancer·2026
Same journal

Horizontal mitochondrial transfer and the tug-of-war between cancer cells and immune cells.

Trends in cancer·2026
See all related articles

Related Experiment Video

Updated: Dec 21, 2025

Generation of 3D Tumor Spheroids for Drug Evaluation Studies
10:33

Generation of 3D Tumor Spheroids for Drug Evaluation Studies

Published on: February 24, 2023

2.7K

3D Spheroids Propel Tumor Characterization.

Shengli Li1, Zhao Zhang1, Leng Han2

  • 1Department of Biochemistry and Molecular Biology, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

Trends in Cancer
|May 20, 2020
PubMed
Summary
This summary is machine-generated.

Researchers used 3D lung cancer spheroids and clustered regularly interspaced short palindromic repeats (CRISPR) screening to identify new cancer targets. This 3D model better mimics tumors than 2D models, revealing carboxypeptidase D (CPD) as a potential therapeutic target.

Keywords:
3D cancer-spheroidsCRISPR screeningcancer vulnerabilitiescarboxypeptidase D

More Related Videos

Longitudinal Morphological and Physiological Monitoring of Three-dimensional Tumor Spheroids Using Optical Coherence Tomography
08:50

Longitudinal Morphological and Physiological Monitoring of Three-dimensional Tumor Spheroids Using Optical Coherence Tomography

Published on: February 9, 2019

8.1K
Three-Dimensional 3D Tumor Spheroid Invasion Assay
12:19

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

59.1K

Related Experiment Videos

Last Updated: Dec 21, 2025

Generation of 3D Tumor Spheroids for Drug Evaluation Studies
10:33

Generation of 3D Tumor Spheroids for Drug Evaluation Studies

Published on: February 24, 2023

2.7K
Longitudinal Morphological and Physiological Monitoring of Three-dimensional Tumor Spheroids Using Optical Coherence Tomography
08:50

Longitudinal Morphological and Physiological Monitoring of Three-dimensional Tumor Spheroids Using Optical Coherence Tomography

Published on: February 9, 2019

8.1K
Three-Dimensional 3D Tumor Spheroid Invasion Assay
12:19

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

59.1K

Area of Science:

  • Oncology
  • Genetics
  • Biotechnology

Background:

  • Accurately modeling in vivo tumors is crucial for understanding cancer driver gene functions.
  • Traditional 2D cell culture models have limitations in replicating the complex tumor microenvironment.

Purpose of the Study:

  • To evaluate the utility of 3D lung cancer spheroids for large-scale clustered regularly interspaced short palindromic repeats (CRISPR) screening.
  • To identify novel cancer driver genes and potential therapeutic targets using an advanced 3D screening model.

Main Methods:

  • Implementation of large-scale CRISPR screening.
  • Utilizing 3D lung cancer spheroids as an advanced cancer model.
  • Comparison of 3D spheroids versus 2D monolayers for screening efficacy.

Main Results:

  • 3D spheroids demonstrated significant advantages over 2D monolayers for CRISPR screening.
  • Novel cancer driver genes were identified through the screening process.
  • Carboxypeptidase D (CPD) was identified as a promising novel therapeutic target.

Conclusions:

  • 3D lung cancer spheroids provide a more effective platform for functional cancer genomics screening.
  • The study highlights the potential of CPD as a therapeutic target for lung cancer treatment.